Suraksha Final Project Work Modified

A PROJECT REPORT ON

PERFORMANCE OF SURAKSHA PHARMA PVT LTD IN CONTRACT MANUFACTURING

BY SUMAN MOOD

Ratna Nilay, Near Flyover, Narayanaguda, Hyderabad-29 Ph.040-66639393 www.cmed.ac.in

A Project Report On

PERFORMANCE OF SURAKSHA PHARMA PVT LTD IN CONTRACT MANUFACTURING

A Project Report submitted in partial fulfillment of the requirement for the award of the degree of

MASTER OF BUSINESS ADMINISTRATION

SUBIMTTED BY

SUMAN.M H.T.NO. 39308CM126 Faculty Guide

Company Guide

Prof. Dr.Y.Ramakrishna (DIRECTOR) Prof.Vamshikrishna

Mr.A.V.N Sreedhar

Faculty Member

Business Manager

CMED-BUSINESS SCHOOL

SURAKSHA PHARMA

NARAYANAGUDA, HYD-29

AMEERPET, HYD-73

www.cmed.ac.in

www.surakshapharma.com

ANNEXURE – I DECLARATION

I hereby declare that this Project Report titled “PERFORMANCE OF SURAKSHA PHARMA PVT LTD IN CONTRACT MANUFACTURING” submitted by me to the Department of Business Management, CMED B-School, Hyderabad, is a bonafide work undertaken by me and it is not submitted to any other University or Institution for the award of any degree diploma / certificate or published any time before.

Name and Address of the Student SUMAN.M 9014120309 Narayanaguda Near Fly Over HYD-29.

Signature of the Student

ANNEXURE – II

CERTIFICATION

This is to certify that the Project Report title “PERFORMANCE OF SURAKSHA PHARMA PVT LTD IN CONTRACT MANUFACTURING” submitted in partial fulfillment for the award of MBA Programme of Department of Business Management, CMED B-School, Hyderabad, was carried out by SUMAN.M under my guidance. This has not been submitted to any other University or Institution for the award of any degree/diploma/certificate.

Name and address of the Guide Prof.Dr.Y.Ramakrishna & Prof.Vamshikrishna CMED B-School Narayanaguda HYD-29.

Signature of the Guide

TABLE OF CONTENTS CONTENTS

PAGE NUMBERS

Acknowledgement

i

Abstract

ii

CHAPTER 1 1. Research Methodology 1.1

Objective of the study

1.2

Need of the study

1.3

Source of the data

1.4

Sample size

1.5

Limitation of the study

1.6

Project schedule

1-4

CHAPTER 2 2. Literature Review 2.1

Pharmaceutical industry Overview

2.2

World Pharmaceutical Industry

2.3

Indian Pharmaceutical Industry

2.4

SWOT Analysis of the Pharma Sector

2.5

Contract Manufacturing

2.6

Contract Manufacturing in India

2.7

Advantages of Contract Manufacturing

5-24

2.6

Comparison of Pharma outsourcing between china and India

CHAPTER 3 3. Company Profile

25-30

3.1

Brief Information of the company

3.2

Vision of the Suraksha Pharma

3.3

Research & Analytical Labs of the Suraksha Pharma

3.4

Contract manufacturing Resources

3.5

Board of Directors

3.6

SWOT Analysis of Suraksha pharma pvt ltd

CHAPTER 4 4. Analysis of the data

31-54

CHAPTER 5 5. Interpretation, Findings & Conclusions 5.1

Interpretation

5.2

Findings and suggestions

5.3

Conclusions

55-61

6. Questionnaires

62

7. Bibliography

64

ACKNOWLEDGEMENT

I state my deep intelligence of thanks to my institution CMED Business School for giving me the great opportunity to work on this project. I wish to acknowledge with deep appreciation for the valuable guidance received from my lecturer Prof. Rama Krishna and Prof. Vamshikrishna who not only encourage me but also took great pain in completing the project. I also thanked Mr. Nageswara Rao, M.D of Suraksha Pharma Contract Manufacturing, for giving the opportunity to undertake this project in the esteemed organization. I would like to profound gratitude A.V.N Sreedhar, Business Manager of Suraksha Pharma Contract Manufacturing, for his valuable support and suggestions. In addition, he has given valuable time and encouragement in completing the project within the specific time. I am grateful to my peers for their wholehearted support and suggestions, which helped me in completion of this project.

M.SUMAN

ABSTRACT Today Indian pharmaceutical companies are very much improved in their infrastructure facilities and developed in manufacturing of the drugs. Because India is a great place to conduct research & development and for contract manufacturing. The availability of capital and scientific manpower in cheaper cost. This was the main advantage for India in contract manufacturing. Suraksha pharmaceutical is one of the good contract manufacturing company. Suraksha pharma was responsible in launching the new molecules like Citalopram, Olanzapine, Quetiapine, Mirazapine, and sertrline and presently one of the leading company in marketing psychiatric medicines. The company market around 65 products having one of the best product mix to maximize sales and achieve growth objectives and maximize profits with optimum expenditure year after year. With this product mix, dosage forms and strengths, technical and marketing strengths, the products are marketed all over India in ethical and franchisee marketing style. As such, suraksha pharma is growing at the rate of 20% year on year in both top line and bottom line areas because of their strong fundamentals. The main objective of the project is to analyze the various problems in contract manufacturing of the suraksha pharmaceutical company. And trying to find out the strengths and weakness of the suraksha pharma in contract manufacturing. It was useful for the find out the performance of the suraksha in contract manufacturing. The clients of suraksha were satisfied with the final product or not.

CHAPTER 1 INTRODUCTION

RESEARCH METHODOLOGY 1. Objectives of the study: 

To understand the satisfaction level of the Suraksha pharma clients in contract manufacturing.



To know the how does the service and how does the final product and find out the problems in Suraksha pharma contract manufacturing.

2. Need of the study: 

Today Indian pharmaceutical companies are focused on the contract manufacturing and research & development. There is a huge competition in contract manufacturing in India.



Most of the foreign companies are invested in the R&D and Contract Manufacturing of the drugs.



The clients are expected good quality and affordable price of the products. And the contract manufacturing companies are providing good service and having good technology to produce good quality product.



In these, huge competition of the world how does Suraksha pharma performance in contract manufacturing. And how does it satisfy the customer. How the clients are, feel about the Suraksha. The need of this project for to know all these aspect.

3. Source of data: What is information present in this report has been written from both primary data and secondary data. A. Primary Data:

Most of the information presented in the report is Primary data. I.e. the data collected from the clients of the company who had manufactured the various products. The database of the target customers in the twin cities has been proved by the company. And the collection of the data through sending the mail to the clients and directly go to the clients and take the data. Some of the clients are given their opinion in Suraksha Pharma Company. B. Secondary Data: The secondary data has been collected from the company and various sources such as website, articles in magazines.

4. Sample size: Sample was collected from the Hyderabad & secenderabad city only. The total sample size is 30 clients. And the collected data from only 25 clients. In these 10 members have given their opinion through mail and 8 members have given their judgment in Suraksha company remaining respondents (7) are fill up the questionnaires in their companies. Total data was collected by using questionnaires, the total questions are 19. These all questions are close-ended questions. In these 4 questions are used to know their demographic information. The collecting data has been analyzed to isolate important information. Standard deviation, variance, mean, percentage have been used to findings the various things in the company.

5. Limitation of the study: The present study is however, subjected to certain limitation which are as follows: A. Geographic scope: The sample used for the study has been taken from the SURAKSHA PHARMA Contract Manufacturing clients of Hyderabad and Secunderabad. B. Frame errors: The total target respondents are 30 but data collected from 25 clients only. The sample units are selected was incomplete as it takes into consideration

only those target customers who had manufactured their drugs during the Period 2008-2009. C. Send the questionnaires through mail to the target people, it is very difficult to get the data from those people. They do not interest to give the data through mail. Only 10 members are given their opinion through mail.

Project Schedule: S.NO

DATE

WORK INFORMATION

1

01-07-09 TO 07-07-09

Training provided by company.

2

08-07-09 TO 17-07-09

To Meet the Clients and Collecting data.

3

20-07-09 TO 26-07-09

Analysis the data

4

27-07-09 TO 31-07-09

Project outlet discussing with the company

5

01-08-09 TO 04-08-09

To complete the project.

6

07-08-09

Final presentation and project submission

CHAPTER 2 LITERATURE REVIEW

PHARMACEUTICAL INDUSTRY OVERVIEW The main aim of a pharmaceutical industry is to provide the good health for the people of society. To achievement of its aim in order to develop the research and discover the new drugs for the society. Every day pharmaceutical industry search for a new effective drugs and develop the Research on the new kind of medicines. In the pharmaceutical industry, they discover the drug and then developed that drug in to the market. The pharmaceutical industry research is to develop different kind of drugs for different kind of diseases. If the companies want to invent new drug in the market there are two ways. One is drug discovery and another one is develop the drug. Pharmaceutical drugs are useful for the human and animal health. It was very necessary in the world. With out this industry it’s very difficult to be in this world. New drugs are not only for treatment of disease and also improving the quality of life and increasing our life. The pharmaceutical sector is the very much important in the worldwide economy. Main diseases in the world are cancer, cardiovascular disease and HIV/aids. To cure that dangerous cancer and cardiovascular disease Pharmaceutical industry done a great job on these diseases.

WORLD PHARMACEUTICAL INDUSTRY The world pharmaceutical industry has been changing because of globalization, and increased competitiveness and fight for global market shares. These are created new challenges for pharmaceutical companies in worldwide. The main characteristics of the world pharmaceutical industry as follows •

Increased globalization & competitiveness

•

Lack of new products

•

Increased investments in research and development (R&D).

•

Development of technologies

•

Quick development of the world generic market.

The world pharmaceutical industry is a one of the most creative so this industry called as HIGH- TECH industry. The world pharmaceutical companies are invest on average 16% of their sales in to R&D, And 26% or more into marketing and sales activities. SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

There are three different groups of the world pharmaceutical company.

WORLD PHARMACEUTICAL COMPANIES

GENERIC PRODUCERS

ORIGINATORS

SPECIALISTS

SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

1. ORIGINATORS: Pharmaceutical companies which work on research and development marketing and sales. 2. GENERIC PRODUCERS: Pharmaceutical companies which work on development and sales of generic products. 3. SPECIALISTS: Pharmaceutical companies which work on research and development of biotechnology and pharmacogenomic products. SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

The world pharmaceutical market will grow by an average of 7% CAGR (Compounded annual growth rate) till the year 2010. The world generic market was growing by 12% average of CAGR till the year 2010. SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

THE WORLD PHARMACEUTICAL MARKET World pharmaceutical market 2000-2005 Year Value in billion $ Growth in % 2000 358 2001 387 8.1 2002 422 9 2003 490 16.1 2004 547 11.6 2005 602 10 SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

The biggest world multinational pharmaceutical companies invest more than 25% of their sales into marketing and sales activities to get global market share. The USA generic market reached to $40 billions in sales in 2005. With the 12% growth rate. ORIGINATOR LEADING WORLD PHARMACEUTICAL COMPANIES IN 2005 Leading world pharmaceutical companies in 2005 (originators) Country of Sales in billion Position Company origin $ 1 Pfizer USA 44.3 2 Sanofi-Aventis France 33.6 3 GlaxoSmithKline United Kingdom 32.1 4 Novartis Switzerland 24.9 5 AstraZeneca United Kingdom 23.9 6 Johnson&Johnson USA 22.3 7 Merck&Co USA 22.1 8 Roche Switzerland 21.5 9 Wyeth USA 15.3 10 BMS USA 15.3

World market share in % 7.4 5.6 5.3 4.1 4 3.7 3.7 3.6 2.5 2.5

SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

LEADING WORLD GENERIC COMPANIES IN 2005 Leading world generic companies in 2005 (generics) Position Company Country of origin 1 Teva Israel 2 Sandoz Germany 3 Merck Generics Germany 4 Ivax USA 5 Ratiopharm Germany 6 Watson USA

Sales in billion $ 5.3 4.7 2.3 1.8 1.7 1.65

SOURCE: http://www.efst.hr/management/vol14no1-2009/4-kesic

The main drivers of globalization are multinational companies. Because •

Multinational companies have strong market position.

•

They have global structure of production.

•

They have global organization of research and development activities.

•

They perform flexible purchasing strategy.

INDIAN PHARMACEUTICAL INDUSTRY The Indian pharmaceutical industry was improved its infrastructure and manufacture the drugs that based on new technologies it has resulted to produce huge amount of drugs in the pharmaceutical. This huge amount drugs produced because of the availability of very skilled new technology and scientific manpower. •

The gross production of drugs in India was crossed an amount of 26,280 million rupees.

•

The growth rate for formulation drugs is 20 percentages.

•

The growth rate for bulk drugs is 15 percentages.

•

The Indian pharmaceutical industry production of drugs has reached new heights.

There are some reasons why the drugs production high in the Indian pharmaceutical industry. Reasons: •

In India has low production cost

•

A very low R&D cost

•

National laboratories has also helped in formulate various medicines

•

Low labor cost

Indian pharmaceutical industry produce quality products and those products are approved by regulatory authorities in USA and UK. The Indian pharmaceutical sector is highly split with more than 20,000 registered units. The leading 250 pharmaceutical companies 70% of market with market leader holding nearly 7% of market share. SOURCE: http://www.economywatch.com/

ADVANTAGE IN INDIA: ADVANTAGE INDIA

KNOWLEDGE -ABLE WORKERS

COST EFFECTIVE CHEMICAL SYNTHESIS

INFORMATION & TECHNOLOGY

GLOBALISATI-ON

CONSOLIDATION

SOURCE: http://www.pharmaceutical-drug-manufacturer.com/

KNOWLEDGEABLE WORKERS: •

India has a group of workers with high technical skills and decision-making.

•

India has an educated workers and English is commonly used.

•

Professional services are easily available.

COST EFFECTIVE CHEMICAL SYNTHESIS: •

Its track the record of improved cost-beneficial chemical synthesis for various drugs molecule is excellent.

•

It provides a wide variety of bulk drugs and export complicated bulk drugs.

INFORMATION & TECHNOLOGY: •

India has a good network of excellent educational institution and has the good power in Information technology.

GLOBALISATION: •

India has 70 million middle class markets in globally.

•

Those pharmaceutical markets are contentiously growing.

CONSOLIDATION: •

The international pharmaceutical industry is finding great opportunities in India.

•

The process of consolidation is generalized phenomenon in the world pharmaceutical industry. That consolidation process started in India. SOURCE: http://www.pharmaceutical-drug-manufacturer.com/

INDIAN PHARMACEUTICAL GROWTH India $3.1 billions pharmaceutical industry is growing at rate of 14 percent per year. Over 20,000 registered pharmaceutical manufacturers exist in the country. •

In 2002 financial year the domestic pharmaceutical industry output is exceed Rs260 billions.

•

The bulk drugs account was Rs54 billions (24%), and remaining 79% for formulation.

•

In 2001 financial year import were Rs20 billions and export were Rs87 billions.

•

To observe these results the import is low and the export to the other countries was high.

•

The production of the drugs was high in the country because of this reasons the export of the drugs to the other country is high compare to the import of the drugs.

•

The Indian pharmaceutical industry was very focused on the research and development (R&D).And improves their knowledge on the development of new

•

Drugs in the industry. They were heavily invested on the research and development. To improve and discover the new drugs in the market.

•

The India 4th rank in the terms of total pharmaceutical production and 13th in term of value.

Over the last two years the pharmaceutical market value has increased to $360 millions because of the launch of new products.3900 new generic products have been launched in the past two years. From the year 1980-2000 the production of bulk drugs increased. In 1980 the production of bulk drugs is 240 croses. In 2000 the production of bulk drugs is 3,777 croses.The production of formulation also increased from the year 1980-2000.In the year 1980 the Indian formulation is 1200 croses.The Indian production formulation in the year 2000 is 15960 croses.The export of the Indian finished formulations and bulk drugs are high from the year 1980-2000.The Indian import composition of bulk drugs and formulations are low compare to the export products. In the present situation only a few people can afford costly drugs, which have increased price sensitivity in the pharmaceutical market. Now the companies are trying to capture the market by introducing high quality and low Price medicines and drugs. Contract research and pharmaceutical outsourcing are the new avenues in the Pharmaceutical market. Contract manufacturing is growing at a very fast pace and is estimated to grow to $30 billion. Where as contract research is estimated to reach $6-10 billions. Indian multi national companies like Dr.reddy’s lab, cipla, ranbaxy etc have created awareness about the Indian market in the international pharmaceutical market. The top MNC’s get approval by Food and Drugs Administration (FDA), and Abbreviated new drug application (ANDA). SOURCE: http://www.pharmaceutical-drug-manufacturer.com/pharma industry-statistics/

INDUSTRY STRENGTHS:

INDUSTRY STRENGTHS

CAPITAL INVESTMENT IN TECHNOLOGY

COST EFFECTIVE

MANPOWER

CONTRACT MANUFACTUR -ING

INFRASTRUC -TURE

GENERIC DRUGS

SOURCE: http://www.naukrihub.com/india/pharmaceutical/overview/

•

CAPITAL INVESTMENT IN TECHNOLOGY: Availability of advanced technology at low cost, the companies can produce drugs At lower costs.

•

COST EFFECTIVE: The filling cost of Abbreviated new drug application (ANDA) low for the Indian companies.

•

MANPOWER: There is a large group of technical experts available here.

•

CONTRACT MANUFACTURING: There is good scope for contract manufacturing & contract research.

•

INFRASTRUCTURE: There is a well-developed infrastructure for the pharmaceutical industry.

•

GENERIC DRUGS: The generic drugs manufacturing segment has received huge investments. The process making generic drugs more competitive and efficient. The essential drugs are available at affordable prices to the vast population of India.

The Indian pharmaceutical industry has given employment to 2.86 millions of people. Indian pharmaceutical industry manufactures over 400 bulk drugs and 60,000 finished medicines are used in formulations. The contract research is increased at the rate of 25% per year, and is expected to touch $380 billions by 2010.The Indian pharmaceutical industry has around 30,000 players, out of which 330 are in Organized sectors. The Indian pharmaceutical industry exports its products to more than 200 countries.

THE INDIAN PHARMACEUTICAL SECTOR: ECONOMIC VALUE •

The industry has grown from Rs.4 billion in 1970 to Rs.290 billions in 2003.

•

A few years ago investment in R&D was very low 0.001% of the total R&D worldwide. But now companies are focusing on the drug discovery and R&D.

•

They are spending over 5% of their turnover on R&D.For the example cipla (4%), cadila (4.45%).

•

The value of India over-the counter medicines (OTCs) market is $940 millions. Growing at the rate of 20% per year.

•

There are 61 FDA approval plants in India which help Indian companies caught the opportunity of contract manufacturing. SOURCE: http://www.naukrihub.com/india/pharmaceutical/economic value/

CLASSIFICATION OF INDIAN PHARMACEUTICAL INDUSTRY: The Indian pharmaceutical industry can be classified in to two types. One is organized and another one is unorganized sector. The organized sector has about 250 manufacturing

and formulation units. On the basis of management control the organization sector can be further classified into MNCs and Indian companies. ON THE BASIS OF PRODUCT MANUFACTURED, THE PHARMACEUTICAL INDUSTRY CLASSIFIED INTO: •

BULK DRUGS: The key component raw material for the manufacture of formulations. (CHLORTHALIDONE USP/EP, PROPOFOL EP, FLUTAMIDE USP/EP)

•

FORMULATIONS: Combinations of different bulk drugs. The classic form for a drug is the pill, a soft, pea-sized ball containing the drug and taken orally. Pharmacists used to roll them by hand. Nowadays pills, or tablets as they are also called, are manufactured in machines and consist of powders that are pressed together to form a compact mass. Formulations amount nearly 81% and remaining bulk drugs account is 19%.

ON THE BASIS OF FORMULATION THE PHARMACEUTICAL INDUSTRY FURTHER CLASSIFIED INTO: •

PRESCRIPTION MEDICINES: Also known as ethical formulation. Prescription medicines are an important part of treating and preventing illness. However, incorrect use of these medicines can make them unsafe, for example, not following instructions about the dose of a medicine, including when to take your medicines and for how long, can make you unwell. SOURCE: http://www.mydr.com.au/travel-health/prescription-medicines

•

OVER-THE-COUNTER MEDICINES : Also known as OTC formulation. Over-the-counter (OTC) drugs are medicines that may be sold to a customer without a prescription from a health care professional, as compared to prescription drugs, which may only be sold to customers possessing a valid prescription Eg: analgesics, cough drug, etc.

SOURCE: http://en.wikipedia.org/wiki/Over-the-counter_drug

ON

THE

BASIS

OF FORMULATIONS

PATENT,

PHARMACEUTICAL

INDUSTRY CAN BE CLASSIFIED AS: •

BRANDED FORMULATIONS: They are ethical formulations prepared by using a bulk drugs. And marketed by single pharmaceutical company.

•

GENERICS: They are formulations they don’t contain any patented bulk drugs and can be manufactured by more than one company. Eg. AMOXICILLIN SOURCE: http://www.naukrihub.com/india/pharmaceutical/classification/

CURRENT SITUATION OF INDIAN PHARMACEUTICAL SECTOR: •

According to the economic survey in 2005-2006 the pharmaceutical industry had achieved a turnover of $12 billions and is expected to grow 13 % in the year 2007

•

Pharma export value reached about $4.7 billions during the year 2005-06.

•

Drugs and pharmaceutical sector is at 8th rank in India’s top 10 FDI attracting sector.

•

According to the economic survey in 2006-07 the value of pharmaceutical output has increased 10 times from the last 15 years. SOURCE: http://www.naukrihub.com/india/pharmaceutical/current scenario/

FUTURE SITUATION FOR INDIAN PHARMACEUTICAL SECTOR: •

The Indian pharmaceutical companies making their presence globally.

•

Competing with the developed countries like Europe, Japan, and United states.

•

India is a good place for R&D and also contract manufacturing and conduct generic research drugs.

•

The market value for R&D and contract manufacturing is $45 billions in 2005.

•

The generic sector expected to grow $100 billions in the next few years.

•

Contract research I India is also growing at the rate of 20-25% per year. SOURCE: http://www.naukrihub.com/india/pharmaceutical/future scenario/

THE FUTURE OF INDIA PHARMACEUTICAL SECTOR IS VERY GOOD •

Clinical trials in India cost is $25 millions each, where as in US the cost is $300350 millions each.

•

Indian pharmaceutical companies are spending 30-50% less on custom synthesis services as compared to its global cost.

•

The Indian new drug cost around $10-15 millions, where as in US the cost is $100-150 millions.

SWOT ANALYSIS OF PHARMA SECTOR: STRENGTHS: •

Cost effective technology

•

Strong and well developed manufacturing base

•

Clinical research and trials.

•

Knowledge based low cost workers in science and technology.

•

High quality formulations and drugs.

•

High standard of purity.

•

World class process development labs.

•

Excellent clinical trials centers.

WEAKNESS: •

Lack of strategic planning.

•

Low R&D investments.

•

Low health care expenditure.

•

Production of duplicate drugs.

•

Fragmented capacities.

OPPORTUNITIES: •

Globalization

•

Drug delivery system management

•

Increased income

•

Production of generic drugs

•

Contract manufacturing

•

Clinical trials & research.

•

Drug molecules

•

New therapeutic products

THREATS: •

Small number of discoveries

•

Competition from MNCs

•

Transformation of process patent to product patent (TRIPS)

•

Outdated sales and marketing methods. SOURCE: http://www.naukrihub.com/india/pharmaceutical/swot analysis/

CONTRACT MANUFACTURING: Contract manufacturing is the process of working agreement between two companies. The manufacturer will handle the order and delivery process for the client. As a result the client does not have to maintain manufacturing facilities, purchase raw materials, or take the labor in order to produce the finished goods. Contract manufacturing is the basic working model widely used into many different Industries. Contract manufacturing used in the pharmaceutical industry, creation of computer components and other electronic goods. Industries like personal care and automotive parts, and medical equipments are created by the contract manufacturing. In the contract manufacturer can be use their facilities to produce quality goods that will meet customer final expectation. There are several advantages to a contract manufacturing arrangement. For the manufacturer there is the guarantee of stable work. In the contract manufacturing have to purchase raw materials, and hire and train the employees to produce the products. Manufacturing company daily face with the employees who fails to report to work, equipment that breaks down. The general concept of contract manufacturing is not limited to the production of goods. Services such as telecommunications, internet access, and cellular services. Can also supplied by a private brand.

WHAT IS CONTRACT MANUFACTURING: Contract manufacturing is the productions of goods by a manufacturer to the external customer. The customer involves the dealer in the quality planning process and provided well documented instruction, drawings and specification. Then the dealers understand the customer expectation on the final products. Both the customer and the dealer should

approach the contract manufacturing with the objective of producing high quality products. This is the period of core competencies and global alliances. Those companies are concentrating on core competencies. The main objective is growing quickly and makes more money. The cost is very important consideration in contract manufacturing. The customer should consider the good quality of products and price of those products, protection of intellectual property, timely delivery, technical expertise, and strong work ethic.

CONTRACT MANUFACTURING IN INDIA: Globally increase in cost of research & development and low productivity. Because of this reason the many foreign companies are invest in low cost and developed countries. •

The global pharma outsourcing market was $57.2 billions in 2007 and it expected to grow at compounded annual growth rate (CAGR) of 10% to reach $76 billions in 2010.

•

The global market for contract research and manufacturing services (CRAMS) in 2007 is estimated to $55.48 billion.

•

Out of total global CRAMS market the contract research was $16.58 billion, contract manufacturing was $38.89 billion.

India with more than 80 US FDA approved manufacturing facilities, India is the one of the favorite location for outsourcing manufacturing services by the multinational companies and global pharmaceutical companies. The Indian contract research and manufacture services (CRAMS) market is $1.21 billions in 2007 and expected to reach $3.16 billion by 2010.India has a large group of well-trained and highly skilled technical personnel’s. Indian manufacturer offer speedy delivery and provide high quality products at affordable price. India is a very good location in the world for manufacturing various products and parts for different industries. The industries are electronics, electrical, automotive, pharmaceutical, medical, plastics and other industries. Many foreign multinational companies are make partnership with Indian companies. And they highly

invested in R&D, manufacturing and marketing fields. The government has put more effort on infrastructure development. That India has the world’s largest supply of highly educated, English speaking, highly skilled manpower in all fields’ labor, IT and engineering, pharmaceutical, accounting, marketing, medicines, and other fields. The contract manufacturing is well developed in India. SOURCE: http://www.contractmanufacturingindia.com/

WHY INDIA FOR CONTRACT MANUFACTURING: •

India got new opportunities in important service, such as contract manufacturing and R&D.

•

The contract manufacture is the production of goods. And the R&D is the research and development of new products.

•

India is a good place for the research and development to discover the new drugs which are helpful to us.

•

India have the excellent opportunities in contract manufacturing mostly all industrial sector. And India has a well trained and skilled technical expert to develop the contract Manufacturing and research and development (R&D).

ADVANTAGES INDIA FOR CONTRACT MANUFACTURING  Availability of skill and efficient workers, English language fluency.  Fast growing domestic market  Quality producers.  Availability of well developed manufacturing units.  Most modern infrastructure and transportation services.  Cost and tax benefits due to the liberal government policies.  Low manufacturing cost compare to other countries.  Availability of land.

 Low formulation cost compare to other countries. SOURCE: http://www.contractmanufacturingindia.com/

India is working to gain major opportunities for contract manufacturing in many Industries. Not only in manufacturer of small components but complete product development. More multinational companies are set the location for manufacturing operations in India. Today India is the place for manufacturing different products in different industries. The Manufacturing industries are pharmaceutical, automobile components, cars and motor cycles, medical equipments. In India faster product development, smart supply chain and development of high technical manufacturing for production of good quality products.

INDIAN CONTRACT MANUFACTURING GLOBALLY The performance of Indian manufacturers is growing rapidly compare to global competitors. India is growing to become the manufacturer center for global world. Improving the infrastructure, reduction of import duties, and the quality improvement in higher educations. Increase investment in research and development (R&D).These are the reasons for the growth of Indian contract manufacturing industry. Indian manufacturer combines with the global multinational companies. To improve production, research and development (R&D), sales and marketing. The most advantage for the India is low cost effective compare to other countries. Contract manufacturing mostly present in all industries like pharmaceutical, automobiles such as cars and motorcycles, electronics and medical equipments. Indian companies are perfected in scientific, technical and manufacturing skills. The service sector and knowledge based industries are unlikely to provide opportunities to the poorly educated section of Indian society. Create more factory jobs and India’s economic growth rate can easily move to 10 percent a year and making it the fastest growing economy in the world. The fast growth

of manufactured sector is very important in increasing Indian economic more than 8 percent annually. SOURCE: http://www.contractmanufacturingindia.com/

ADVANTAGES OF CONTRACT MANUFACTURING: •

Contract manufacturing is a hot opportunity for India.

•

The Indian contract manufacturing market was $874 millions in 2007.

•

Contract manufacturing market gets the opportunities from globally.

•

Availability of land, low cost advantage, strong chemistry.

•

Improving infrastructure.

•

Lower capital requirement.

•

Strong motivation and encouragement from the government.

•

Contract manufacturing was expected to grow strongly in next 5 years.

•

In 2012 the Indian contract manufacturing industry expected to 8% of the total Global market.

•

India will become a major hub for outsourcing formulations.

•

Contract manufacturing industry was provided more employment to the India. SOURCE: http://www.contractmanufacturingindia.com/

COMPARISON OF PHARMA OUTSOURCING BETWEEN CHINA AND INDIA The total global pharmaceutical industry facing a number of challenges they were require to follow more efficient research & development (R&D) and Manufacturing drugs. Outsourcing is a successful for drug companies. China and India countries are increasing very quickly and become stars in the global Pharmaceutical outsourcing. Both the countries possess equal advantages that are low cost and quality service. In many features India and china are very similar. Both countries are located at Asia, and developed

countries with low wages for workers in most industries. China is better industry infrastructure than India. China is better in education of biology than India and biotechnology industry in china is more advanced than India. Indian pharmaceutical companies are invested more in research & development than Chinese

companies. Chinese companies possess stronger capabilities in R&D and Manufacturing of macro compounds than Indian companies. India and china companies provide similar service and qualities. •

India companies possess better skills and capabilities in formulation, manufacturing and marketing of generic drugs than china companies.

•

All major pharma and biotech companies are hundreds of millions of dollars in china to establish their own R&D centers and manufacturing and marketing facilities.

•

The pharma outsourcing industries in both countries are growth rapidly.

•

In china the value is $1.42 billions and in India value is $1.77 billions.

•

Both countries are occupying 2% share in the global pharma outsourcing market. China will have higher future growth than India.

•

At Present, India is better than china in small molecule drug R&D and manufacturing.

•

India offers better quality products, where in china has more cost reduction advantage. SOURCE: http://www.contractmanufacturingindia.com/

CHAPTER 3 COMPANY PROFILE

BRIEF INFORMATION ON THE COMPANY Suraksha Pharma pvt. Ltd a pharmaceutical formulation unit established in Roorkee, uttaranchal state to capture the market share in this growing market with a well defined manufacturing and marketing infrastructure. The plant has good facilities for product development, stability testing, analytical research & development, production, quality control, quality assurance, storage of raw materials, packaging materials and labels etc. SOURCE: http://www.surakshapharma.com/

BREIF INFORMATION ON THE GROUP Manepalli group of companies were incorporated by Sri Nageswara rao in Bhimavaram, andrapradesh, India. Today the group has 3 decades of experience they providing quality medicines for all age groups. Today the vision of Chairman Sri M.V.K Nageswara Rao the group has made into pharmaceutical world, and growing great heights. The group contains 3 companies. SOURCE: http://www.surakshapharma.com/

MANEPALLI GROUP

SUMAGES PHARMA

SUMAC PHARMA

SURAKSHA PHARMA

1. SUMANGES PHARMA PVT LTD: The company establishes at Bhimavaram.This company was incorporated in the year 1985. The company deals in the manufacturing of pharmaceutical formulation, which include tablets (beta lactum and non beta lactum section) capsules (beta lactum and non beta lactum section), liquid orals, and ointments. 2. SUMAC PHARMA PVT LTD: The company was located at the prashanti nagar, kukatpally, Hyderabad. It was established in the year 1992. The company deals in the manufacturing of pharmaceutical formulation, which includes tablets, capsules, and liquid orals. 3. SURAKSHA PHARMA PVT LTD: Suraksha pharma was established in the year 2003 April. It corporate office at Nagarjuna nagar, Ameerpet, Hyderabad. And the company factory located at Opp.Roorkee pharmacy college, kharondi, Roorkee. It’s as exclusive Psychiatry division having nearly 80 latest & new molecules. The marketing operations are located across the India in AndraPradesh, kerala, orissa, Karnataka and part of maharastra.

VISION OF THE SURAKSHA PHARMA: The Suraksha pharma will have a great and clear vision of the future. We will coming up with bulk drugs, clinical research organization, and basic drug research. SOURCE: http://www.surakshapharma.com/

The suraksha pharmaceutical having only the psychiatry division. And the company having nearly 50 latest & new molecules. Formulations are outsourced from 6 major pharma players. For the first time in psychiatric division suraksha has well designed and developed Escitalopram and valdecoxib in soft gel technologies. SOURCE: http://www.surakshapharma.com/

ROORKEE RESEARCH & ANALYTICAL LABS PRIVATE LTD Rookee labs is a commercial testing lab situated in Roorkee uttaranchal has been operation since 2006 and has already enrolled numerous clients across the India. Its includes analytical technology, analytical chemistry, microbiology, quality control, analytical method development & validation, quality control testing, stability testing of active drug substance and finished dosage form, microbiological aspects of product development. Suraksha pharma pvt ltd has obtained license from Drugs Control Administration of Uttarakhand.

TYPES OF PRODUCT MANUFACTURED ON THE SITE: This plant is designed to manufacture oral solid dosage forms, non B-lactum tablets, and capsules. There are no toxic or hazardous substance handled in this plant. In future if there is a need to handle toxic or hazardous substances, proper safety standard and written procedures will be instituted. Pharmaceutical dosage forms for human use only.

LOCATION ADVANTAGES OF ROORKEE: •

Second largest town of uttaranchal.

•

Located close to national capital Delhi 250km.

•

Near to state capital dehradun 52km.

•

Excellent connectivity through board guage railway line and national high way.

•

Vibrant economic center.

CONTRACT MANUFACTURING RESOURCES: •

Suraksha pharma is pharmaceutical formulation third party manufacturing company having schedule “M’ GMP. Their unit was established in Roorkee (uttaranchal). It is a 100% excise free zone.

•

At present they were manufacturing wide range of formulation covering both beta and non beta lactum section in Alu-Alu packing and combi pack for both tablets and capsules.

•

The capacity of Tablets (film, uncoated, enteric coated) is 3 crore per month. And the capacity of capsule is 1 crore per month.

•

Suraksha pharma unit has been specially designed to provide quality products & prompt delivery. We request you to kindly consider our proposal & utilize our facility& experience for manufacturing your products.

BOARD OF DIRECTORS: The board of director of the company was 3 members. They have well experience in the fields of science, technology and management. 1. Mr.NAGESWARA RAO GUPTA MANEPALLI, M.Pharm, (Ph.D) MANAGING DIRECTOR-SURAKSHA PHARMA PVT LTD.

2. Mr.SOMESWARA RAO MANEPALLI, M.Sc Chemical Engineering, USA. DIRECTOR-SURAKSHA PHARMA PVT LTD.

3. Mr.SATYANARAYANA MURTHY MANEPALLI, MBA DIRECTOR-SURAKSHA PHARMA PVT LTD.

SOURCE: http://www.surakshapharma.com/

SWOT ANALYSIS OF SURAKSHA PHARMA PVT LTD

STRENGTH WEAKNESS Strong R&D Well established Brand image Association with MNC’s Best quality Affordable price Located in excise free zone Equipped with modern

Over loaded Labor problems Lack of skilled labors Power cuts Slow bandwidth (internet, phone)

technology

SWOT ANALYSIS OF SURAKSHA PHARMA PVT LTD

OPPORTUNITIES Plants to set up injectables, ointments & syrups. Plans to set permission from D.C.G.I for new molecules Backward integration into bulk drugs.

THREATS Govt policies on DPCO, FDC and license policies. High attrition rate of employees High paid salaries Cross culture collision

CHAPTER 4 ANALYSIS OF THE DATA

Gender

Statistics N

Valid Missing

25 0

Mean

1.24

Std. Deviation

.436

Variance

.190

Valid

male female

Frequency 19 6

Percent 76.0 24.0

Valid Percent 76.0 24.0

Total

25

100.0

100.0

Cumulative Percent 76.0 100.0

Gender

20

15

76.0%

y c n u q re F

10

5 24.0%

0 male

female

Gender

The above graph reveals that the total respondents are 25 members. These 25 members are clients of Suraksha pharma contract manufacturing department. In these 25 members the 76% of the respondents (19) are belongs to male group. And remaining 24% of the respondents (6) are belongs to female group.

Age Statistics N

Valid Missing

25 0

Mean

2.88

Std. Deviation

.781

Variance

.610

Valid

20-24 25-29 30-34 >35 Total

Frequency 1 6 13 5 25

Percent 4.0 24.0 52.0 20.0 100.0

Valid Percent 4.0 24.0 52.0 20.0 100.0

Cumulative Percent 4.0 28.0 80.0 100.0

Age

14

12

10

y c n u q re F

8 52.0%

6

4 24.0%

20.0%

2 4.0% 0 20-24

25-29

30-34

>35

Age

The graph tells about the different age group people. Only one person belongs 20-24 age group. In addition, the 6 members are 25-29 years age group. 13 responders are fit in 30-34 years age group. The remaining members are belongs to above 35 years age group members. To observe in this graph the 3034 years members are high compare to other age group members. This is because the contract manufacturing is the manufacture the drugs these type of field require high qualified persons.

Experience Statistics

N

Valid Missing

25 0

Mean

2.80

Std. Deviation

1.000

Variance

1.000

Valid

0-2 Years 2-4 Years 4-6 Years >6 Years Total

Frequen cy

Percent

Valid Percent

Cumulative Percent

3

12.0

12.0

12.0

6

24.0

24.0

36.0

9

36.0

36.0

72.0

7

28.0

28.0

100.0

25

100.0

100.0

Experiance

10

8

y c n u q re F

6

36.0% 4 28.0% 24.0% 2 12.0%

0 0-2 Years

2-4 Years

4-6 Years

>6 Years

Experiance

In the total respondents, 9 members are having 4-6 years experience and 7 members are having above 6 years experience. In 2-4 years group having 6 members and remaining only one member belongs to 0-2 year’s group. To observe these things the 4-6 years experienced members are high than other. In the age group, members are high in 30-34 years and it was related to experienced persons. The people who having 30-34 years they have the 4-6

years experience in contract manufacturing. The 7 members are having high experience (above 6 years). The remaining members are not having high experience in contract manufacturing.

Qualification Statistics N

Valid Missing

25 0

Mean

1.92

Std. Deviation

.640 .410

Variance

Valid

Graduate Post Graduate professio nal Total

Frequenc y 6

Percent 24.0

Valid Percent 24.0

Cumulative Percent 24.0

15

60.0

60.0

84.0

4

16.0

16.0

100.0

25

100.0

100.0

Qualification

15

12

9

y c n u q re F

60.0% 6

3

24.0% 16.0%

0 Graduate

Post Graduate

professional

Qualification

In the education qualification of the respondents are different from one to another. In the total respondents, 60% of the members are post graduation. And the 24% of the members belongs to graduation. And the remaining members are

professional. In these medical field most of the members are completed their post graduation. In addition, high respondents are qualified post graduation. The fewer respondents are professionals.

How did you feel about the suraksha pharmaceutical company? Statistics N

Valid Missing

25 0

Mean

1.60

Std. Deviation

.500

Variance

.250

Valid

Very good Good Total

Frequency

Percent

Valid Percent

Cumulative Percent

10

40.0

40.0

40.0

15

60.0

60.0

100.0

25

100.0

100.0

How did you feel about the suraksha pharmaceutical company? 15

12

9

y c n u q re F

60.0% 6 40.0%

3

0 Very good

Good

How did you feel about the suraksha pharmaceutical company?

The total respondents are reveals that the Suraksha pharmaceutical company performance was good. The total respondents are feel better about the company. In the total respondents, 40% of the members are announced that the Suraksha

pharma company performance was very good. And the remaining 60% of the respondents are declare that the Suraksha pharma company was good.

Were you satisfied with the quality and price of the products? Statistics N

Valid Missing

25 0

Mean

1.88

Std. Deviation

.332

Variance

.110

Valid

Very satisfied Satisfied Total

Frequency

Percent

Valid Percent

Cumulative Percent

3

12.0

12.0

12.0

22

88.0

88.0

100.0

25

100.0

100.0

Were you satisfied with the quality and price of the products?

25

20

y c n u q re F

15

88.0% 10

5

12.0% 0 Very satisfied

Satisfied

Were you satisfied with the quality and price of the products?

Most of the people declare that the Suraksha pharma company provided quality and affordable price of the product to the clients. In the total respondents 22 members are satisfied with the quality and price of the products. And the remaining 3 members are very satisfied with the price and quality of the Suraksha pharma products. the quality and price is the very important to the

client they were very strictly about that. But the Suraksha product quality and price was attracted to the customers. They give the quality and affordable price to the total clients. The clients were not giving any complaints on the quality and price of the Suraksha products.

On time delivery the product

Statistics N

Valid Missing

25 0

Mean

3.28

Std. Deviation

1.100

Variance

1.210

Valid

Very good Good

Frequency

Percent

Valid Percent

Cumulative Percent

2

8.0

8.0

8.0

5

20.0

20.0

28.0

Cant say

3

12.0

12.0

40.0

Bad

14

56.0

56.0

96.0

Very bad

1

4.0

4.0

100.0

Total

25

100.0

100.0

On time delivery the product

14

12

10

8

y c n u q re F

56.0% 6

4 20.0%

2

12.0%

8.0%

4.0%

0 Very good

Good

Cant say

Bad

Very bad

On time delivery the product

The above graph state that the most of the respondent are not satisfied with the delivery of the products. In the total respondents 60% of the members are declare that the time delivery of the product bad. The 28% of the respondents are stated that the delivery of the product by Suraksha was good. The suraksha pharma company delivery the product on the time. Those clients are satisfied with the delivery time. But 12% of the respondents are cant say about the delivery time of the product. In the total respondents the most of the respondents are not satisfied with the delivery of the product by suraksha. The suraksha pharma company was not delivery the product to the client on the time.

Manufactured products packaging? Statistics

N

Valid Missing

25 0

Mean

1.88

Std. Deviation

.781

Variance

.610

Valid

Very good Good

Frequency

Percent

Valid Percent

Cumulative Percent

6

24.0

24.0

24.0

18

72.0

72.0

96.0

Very bad

1

4.0

4.0

100.0

Total

25

100.0

100.0

Manufactured products packaging?

20

15

10

y c n u q re F

72.0%

5 24.0%

4.0%

0 Very good

Good

Very bad

Manufactured products packaging?

In the total respondents, the most of the members are stated that the suraksha pharmaceutical company manufactured product packaging was very good. The 96% of the clients are satisfied with the product packaging of the suraksha pharmaceutical and the remaining 4% clients are not satisfied with the product packaging. The product packaging is the very important in the transportation of the goods. The suraksha pharma take care about the product packaging. Because of this reasons the most of the clients are not give any complaints on the product packaging.

Product identification? Statistics N

Valid Missing

25 0

Mean

1.84

Std. Deviation

.374

Variance

.140

Valid

Very good Good Total

Frequency

Percent

Valid Percent

Cumulative Percent

4

16.0

16.0

16.0

21

84.0

84.0

100.0

25

100.0

100.0

Product identification?

25

20

y c n u q re F

15

84.0%

10

5

16.0% 0 Very good

Good

Product identification?

The above graph reveals that the product identification of suraksha Pharma Company was very good. In the total respondents 84% of the members stated that the suraksha pharma manufactured product identification is good and the remaining 16% of the members are tells that the manufactured product identification of suraksha pharma is very good. In the total respondents are gave the positive result towards the product identification. The product identification is

very important to the company to recognize of the product is depends upon the product labeling. The most of the respondents are satisfied with the product identification. Suraksha pharma after manufacture the product give the good identification to the product.

Machine technology of the suraksha? Statistics N

Valid Missing

25 0

Mean

1.76

Std. Deviation

.436

Variance

.190

Valid

Very good Good Total

Frequency

Percent

Valid Percent

Cumulative Percent

6

24.0

24.0

24.0

19

76.0

76.0

100.0

25

100.0

100.0

Machine technology of the suraksha?

20

15

10

y c n u q re F

76.0%

5 24.0%

0 Very good

Good

Machine technology of the suraksha?

For the contract manufacturing companies are depends upon the machine technology. The company having good machine technology they can provided good quality product in fewer days. Here the graph stated that the suraksha having the good machine technology to manufacture the products. clients are very satisfied with the machine technology of the suraksha. The total respondents are reveals that the modern machine technology present at the suraksha pharma company. By using this machine technology the suraksha pharma manufactured more products to the different companies.

Technical resources of the suraksha? Statistics N

Valid Missing

25 0

Mean

2.04

Std. Deviation

.455

Variance

.207

Valid

Very good Good

Frequency

Percent

Valid Percent

Cumulative Percent

2

8.0

8.0

8.0

20

80.0

80.0

88.0

Cant say

3

12.0

12.0

100.0

Total

25

100.0

100.0

Technical resources of the suraksha?

20

15

80.0%

y c n u q re F

10

5

12.0%

8.0% 0 Very good

Good

Cant say

Technical resources of the suraksha?

Most of the respondents are declare that the suraksha pharma company having the good technical resources. In the total respondents 88% of the members gave the positive report toward suraksha. The availability of technical resources of suraksha pharma useful to the manufacture the products. This was very helpful to the manufactured product. The suraksha pharma having good technical resources to produce the high level of quantity products. The remaining 12% of the respondents are cant say about the technical resources of the suraksha pharma contract manufacturing.

There any problem with the packaging? Statistics

N

Valid Missing

25 0

Mean

3.56

Std. Deviation

1.003

Variance

1.007

Valid

Strongly agree Agree Cant say Disagree Strongly disagree Total

Frequency

Percent

Valid Percent

Cumulative Percent

1

4.0

4.0

4.0

4 2 16

16.0 8.0 64.0

16.0 8.0 64.0

20.0 28.0 92.0

2

8.0

8.0

100.0

25

100.0

100.0

There any problem with the packaging?

20

15

y c n u q re F

10 64.0%

5

16.0% 0

8.0%

4.0% Strogly agree

Agree

Cant say

8.0% Disagree

Strogly disagree

There any problem with the packaging?

In the total respondents the 18 members are stated that the suraksha pharma products packaging was very good. They don’t face any problem with the packaging of the products. The 5 members are says that the product packaging is very bad. There was a problem with the product packaging. They doesn’t satisfied with the product packaging. The remaining 2 respondents are cant say about the packaging problem. The most of the respondents are reveals that the suraksha company takes care about the manufactured product packaging.

Did the final product meet your requirements? Statistics N

Valid Missing

25 0

Mean

1.80

Std. Deviation

.707

Variance

.500

Valid

Strongly agree Agree

Frequency

Percent

Valid Percent

Cumulative Percent

8

32.0

32.0

32.0

15

60.0

60.0

92.0

Cant say

1

4.0

4.0

96.0

Disagree

1

4.0

4.0

100.0

Total

25

100.0

100.0

Did the final product meet your requirements?

15

12

9

y c n u q re F

60.0% 6

32.0% 3

0 Strogly agree

Agree

4.0%

4.0%

Cant say

Disagree

Did the final product meet your requirements?

The above graph reveals that the suraksha pharma manufacturing products are provide exact requirements for their clients. The most of the respondents (23) are stated that the final products are having their requirements. The suraksha pharma by using their technology they produce product. The clients are getting their requirements in that final products. The 1 member declares that he was cant say about the final product. The remaining one member stated that he doesn’t get the requirements in the final products.

Was the quality of customer service you received? Statistics N

Valid Missing

25 0 1.84 .473 .223

Mean Std. Deviation Variance

Valid

Strongly agree Agree Cant say Total

Frequency

Percent

Valid Percent

Cumulative Percent

5

20.0

20.0

20.0

19 1 25

76.0 4.0 100.0

76.0 4.0 100.0

96.0 100.0

Was the quality of customer service you received?

20

15

10

y c n u q re F

76.0%

5

20.0% 4.0%

0 Strogly agree

Agree

Cant say

Was the quality of customer service you received?

The most of the respondents (24) are declare that the suraksha pharma company

provides the good quality of customer service to the clients. The respondents are very satisfied with the customer service of the suraksha pharma company. The remaining only one member can’t say about the customer service of the suraksha pharma.

The customer service representative handled my cal quickly Statistics N

Valid Missing

25 0

Mean

1.40

Std. Deviation

.577

Variance

.333

Valid

Strongly agree Agree

Frequency

Percent

Valid Percent

Cumulative Percent

16

64.0

64.0

64.0

8

32.0

32.0

96.0

Cant say

1

4.0

4.0

100.0

Total

25

100.0

100.0

The customer service representative handled my cal quickly

20

15

y c n u q re F

10 64.0%

5 32.0%

4.0%

0 Strogly agree

Agree

Cant say

The customer service representative handled my cal quickly

The above graph that the 16 respondents are strongly stated the suraksha pharma company handled their cal quickly. They don’t neglect the clients. And

the 8 members are also says that the suraksha company receive the cal quickly. The remaining only one respondent is cant say about the customer service representative. In the total respondents, 24 members are satisfied with the customer service representative of the suraksha pharma company. They were receive cal quickly with out create any problem to the customer.

My cal quickly transferred to the person who best could answer my question Statistics Valid Missing

N

25 0

Mean

2.08

Std. Deviation

.702

Variance

.493

Valid

Strongly agree Agree Cant say Disagree Total

Frequency

Percent

Valid Percent

Cumulative Percent

4

16.0

16.0

16.0

16 4 1 25

64.0 16.0 4.0 100.0

64.0 16.0 4.0 100.0

80.0 96.0 100.0

My cal quickly transferred to the person who best could answer my question 20

15

y c n u q re F

10 64.0%

5

16.0%

16.0% 4.0%

0 Strogly agree

Agree

Cant say

Disagree

My cal quickly transferred to the person who best could answer my question

The most of the respondents (80%) stated that they were get good answer from the exact person who answers their questions. The customer service representatives if they were do not have exact information they quickly transfer the cal to the person who best give the correct information. The 16% respondents are declaring that they cannot say about the transfer of the cal to the higher authorities. The remaining only one is says that the suraksha customer service representative not transfer the cal to the higher authority.

How likely are you to recommend product to the others Statistics

N

Valid Missing

25 0

Mean

1.80

Std. Deviation

.408

Variance

.167

Valid

Very likely Likely Total

Frequency

Percent

Valid Percent

Cumulative Percent

5

20.0

20.0

20.0

20

80.0

80.0

100.0

25

100.0

100.0

How likely are you to recommend product to the others

20

15

80.0%

y c n u q re F

10

5

20.0%

0 Very likely

Likely

How likely are you to recommend product to the others

The 20% of the respondents are declaring that they were very interested to recommend the product to the others. The remaining 80% of the respondents stated they likely to advise the product to other. All respondents are probably advice to the others. Suraksha pharma performance good in contract manufacturing. They were manufactured product very quickly. The clients are very satisfied with the suraksha pharma company. Because of this reason they were recommend to the other.

Customer service solve your problems quickly Statistics N

Valid Missing

25 0

Mean

2.04

Std. Deviation

.539

Variance

.290

Valid

Strongly agree Agree

Frequency

Percent

Valid Percent

Cumulative Percent

3

12.0

12.0

12.0

18

72.0

72.0

84.0

Cant say

4

16.0

16.0

100.0

Total

25

100.0

100.0

Customer service solve your problems quickly

20

15

10

y c n u q re F

72.0%

5

16.0%

12.0% 0 Strogly agree

Agree

Cant say

Customer service solve your problems quickly

Most of the respondents (21) are stated that the suraksha pharma company solves their problem quickly. The customer service of the suraksha very effective and they solve the client’s problems very quickly. The remaining 4 members are cant say about the customer service solve the problem.

Overall how would you rate the suraksha pharmaceutical

company? Statistics N

Valid Missing

25 0

Mean

1.80

Std. Deviation

.408

Variance

.167

Valid

Very good Good Total

Frequency

Percent

Valid Percent

Cumulative Percent

5

20.0

20.0

20.0

20

80.0

80.0

100.0

25

100.0

100.0

Overall how would you rate the suraksha pharmaceutical company? 20

15

80.0%

y c n u q re F

10

5

20.0%

0 Very good

Good

Overall how would you rate the suraksha pharmaceutical company?

The above graph tells that the all respondents were gave the good rate for the

suraksha pharma company. The 20% of the respondents are gave very good rate for the suraksha pharma company. And the remaining 80% of the respondents are gave the good rate for the company. The 20% of the respondents are most favorable towards the suraksha pharma company. They were very satisfied with the company. And the 80% of the respondents are gave little bit favor to the suraksha pharma company. The all respondents give the positive result to the suraksha pharma company because they get good quality and affordable price. In addition, get good customer service representative, the delivery of the product and do not have any problem in packaging products. if they have any problem they get quickly solve their problem. These are the reasons for the respondents given good rate for the suraksha pharma company.

CHAPTER 5 INTERPRETATION FINDING & CONCLUSIONS

INTERPRETATION: Contract manufacturing is the process of manufacture the products by the manufacturer. The customer give the instruction to the manufacturer on the quality planning process and

provided document instruction, drawing and specification. Then the manufacture understand the customer expectation on the product, the contract manufacturer manufacture the product with customer expectation. The manufacturer fulfills the customer expectation on the products. When the contract manufacturer manufactures the products at affordable price and quality products, the customers are also attract the manufacturer. The cost is very much important in the contract manufacturing, the customer consider the good quality of the product and price of that product, Protection of intellectual property, timely delivery, technical resources of the company, strong work ethic. So the contract manufacture company can satisfied the customers in good quality product and affordable price, protection of intellectual property, timely delivery, used new technology, maintain good service representative to give a quick and current answer to the customer. To maintain all those characters the contract manufacturing company wills growth strongly in the competition world. In this contract manufacturing India is a good place for manufacturing the product. The India will become good manufacturing industry in the world. The India will have the advantages in availability of efficient workers and fast growing domestic market, availability of well developed manufacturing units, most modern infrastructure, availability of land, low formulation cost compare to other countries. Suraksha pharma good drugs manufacturing company. Suraksha pharma company is the one of the leading contract manufacturing company in psychiatric products. Suraksha research and analytical labs private ltd present in Roorkee. It has analytical technology, analytical chemistry, and quality control testing, stability testing of active drug substance

and finished dosage form. Suraksha have a good manufacturing technology. Above 50 companies are manufactured different products at suraksha pharma. The client of suraksha well satisfied with the service of the suraksha. Doing the project on the suraksha to find out the satisfaction level of the customer in contract

manufacturing of the suraksha pharma. The customers are only the way to find out the results. In the 30 numbers of companies in that 25 numbers of clients responded for this project. Remaining clients are not interested to give their opinion on the company. •

In that total respondents 19 members are male and remaining 6 members are belongs to female group.

•

Most of the clients (13) are belongs to 30-34 years age group members.

•

In total 25 members 15 members are done their post graduation.

•

Based on the research the satisfaction level of the clients high towards good about the company.

•

The clients are declaring that they agree with the suraksha pharma products are very good quality products and they give those products at affordable price. The customers are highly satisfied at the quality of the product and price of the product. These two things are very important to the contract manufacturing. To increase the customer in to high level to capture the clients value to provide good quality products at cheaper cost and provide a valuable service to the customers.

•

Suraksha pharma clients are stated that the suraksha have a good machine technology to manufacture the products and have good technical resources.

•

The customer service representative of the suraksha well, they give a quick response to the cal of the customer, and give current answer to that clients if they don’t give the answer they quickly that cal should transfer to the higher deportment who will give the current answer to that call. This customer service also satisfy the customer at good level.

•

Suraksha manufactured product are very good there is no problem in manufactured products and the product identification is very good, the customers don’t face any problem with the packaging of the final product.

•

On this research the most of the clients are declare that the suraksha pharma don’t delivery the final product on the time, they were faced problem with the on the time delivery.

•

And the final product also very good that product fulfill the customer requirements as in good level.

•

Overall the performance of the suraksha pharma in contract manufacturing is excellent. All the clients are given good rate for the suraksha.

To consider all those things the suraksha pharma performing well in contract manufacturing. In the future the suraksha will become a no.1 Contract Manufacturing company in India.

FINDINGS: Suraksha pharma company performance in contract manufacturing is very good. The production of the product was good quality and they give that product to the clients with affordable price. And the suraksha pharma play a great role in contract manufacturing. Suraksha pharma also launched new molecules. Presently the suraksha pharma one of the leading company in marketing psychiatric medicines all over India.



Most of the clients are declare that the suraksha manufactured products are having good quality and they give that product at cheaper cost. In that quality and price of the product customers are well satisfied with the suraksha contract manufacturing.



After manufacture the product should be delivered to the particular clients. Because of the transportation problems that products were not delivered at particular time. Clients are very much trouble with the delivery of the product by

suraksha. But 28% of the clients are satisfied with the delivery of the products, they were getting the product on the time.



The product packaging of the suraksha is very good. The clients are don’t give any complaint on the suraksha. By considering all those things the suraksha manufactured product packaging is very convenience to the clients.



Suraksha pharma well take care about the manufactured product identification. Do not have any complaints from the clients.



Machine technology used by suraksha was excellent; they were using latest technology to produced quality products.



72% of the clients are stated that there is no problem with the product packaging by suraksha pharma pvt ltd.



Most of the clients (92%) are pronouncing that the final manufactured product meet all their requirements.



The customer service representative of the suraksha performing well. They were solving the problem very quickly. And if they were not answer the problem of client, they quickly transfer that cal to the higher authority of the company.



Finally the all clients of suraksha declared that the suraksha is a very good contract manufacturing company. They were very satisfied with the suraksha pharma contract manufacturing company.

SUGGESTIONS:

The main objective of doing this project is to find out the performance of suraksha in contract manufacturing and what are problems faced the customers of Suraksha Pharma. •

To analyze the data the most of the clients (60%) are stated that the suraksha delivery of the final manufactured product is very late. They do not deliver the product on the time. By considering the final information of the data, the suraksha should improve the on time delivery of the products. The clients are very dissatisfied with the delivery of the product.

•

The delivery of the product totally not bad the 28% of the clients are satisfied with the on time delivery the product.

•

In that total respondents 20% of the people are faced a problem with the product packaging. The product packaging is not good. Suraksha pharma should take care about the product packaging.

CONCLUSIONS:

The Suraksha pharma pvt ltd has a great vision about the future. The Suraksha pharma having a great lab for contract manufacturing of the new drugs. They were manufactured at Roorkee uttaranchal. In Roorkee having a research & analytical labs private ltd. Different types of products are manufactured at this site. They were designed to manufacture oral solid dosage forms, non B-lactum tablets, and capsules. There are no toxic or hazardous substance handled in this plant. Pharmaceutical dosage forms are manufactured only for human use. At present they were manufacturing wide range of formulation covering both beta and non beta lactum section in Alu-Alu packing and combi pack for both tablets and capsules. The capacity of Tablets (film, uncoated, enteric coated) is 3 crore per month. And the capacity of capsule is 1 crore per month. According to the research results the Suraksha pharma pvt ltd contract manufacturing is very good. All of their clients are satisfied with their service. And Suraksha contract manufacturing taking care about quality of the product and they give that product at affordable price. Product manufacturing packaging and product identification is very good. Suraksha using good machine technology for manufacturing the product. Having a great technical resources and final product meet clients expectation. The customer service is very good. Suraksha pharma solve the customer’s problem quickly. The great success of Suraksha in contract manufacturing is they provide quality service to the clients. But most of the customers given complaint on delivery of the product. The final products were not delivered on the time. All the customers were given a good rate for Suraksha performance in contract manufacturing. Overall Suraksha pharma pvt ltd providing very high-quality manufactured drugs to the customers. Suraksha pharma Performance in contract manufacturing has attracting the customers towards manufacturing new drugs.

QUESTIONNAIRES

PERFORMANCE OF SURAKSHA PHARMA PVT LTD IN CONTRACT MANUFACTURING 1. How did you feel about the suraksha pharmaceutical company? 1. Very good 2.good 3.cant says 4.bad 5.very bad 2. Were you satisfied with the quality and price of the products? 1. very satisfied 2.satisfied 3.cant say 4.dissatisfied 5.very dissatisfied 3. On time delivery the product 1. Very good 2.good 3.cant say 4.bad 5.very bad 4. Manufactured products packaging? 1. Very good 2.good 3.cant say 4.bad 5.very bad 5. Product identification? 1. Very good 2.good 3.cant say 4.bad 5.very bad 6. Machine technology of the suraksha? 1. Very good 2.good 3.cant say 4.bad 5.very bad 7. Technical resources of the suraksha? 1. Very good 2.good 3.cant say 4.bad 5.very bad 8. There any problem with the packaging? 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree 9. Did the final product meet your requirements? 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree 10. Was the quality of customer service you received? 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree 11. The customer service representative handled my cal quickly 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree 12. My cal quickly transferred to the person who best could answer my question 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree

13. How likely are you to recommend product to the others 1. Very likely 2.likely 3.cant says 4.unlikely 5.very unlikely

14. Customer service solve your problems quickly 1. Strongly agree 2.agree 3.cant say 4.disagree 5.strongly disagree 15. Overall how would you rate the suraksha pharmaceutical company? 1. Very good 2.good 3.cant say 4.bad 5.very bad DEMOGRAPHIC INFORMATION GENDER 1. Male 2.female AGE 1.20.24 2.25-29 3.30-34 4.>35 EXPERIENCE 1.0-2 years 2.2-4 years 3.4-6 years 4.>6 years QUALIFICATION 1. Graduates 2.post graduates 4.professional.

BIBLIOGRAPHY

http://www.google.com/ http://www.researchandmarkets.com/ http://www.surakshapharma.com/ http://www.efst.hr/management/vol14no1-2009/4-kesic http://www.economywatch.com/ http://www.pharmaceutical-drug-manufacturer.com/ http://www.naukrihub.com/india/pharmaceutical/overview/ http://www.contractmanufacturingindia.com/